Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 12 Feb 2025 | 6 Feb 2025 |
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the Unaudited (Standalone And Consolidated) Financial Results of the Company for the Quarter And Nine Months Ended December 31 2024. Unaudited Financial Results for the third quarter and nine months ended 31 December 2024 (As Per BSE Announcement Dated on: 12/02/2025) | ||
Board Meeting | 7 Nov 2024 | 29 Oct 2024 |
Quarterly Results As per attachment (As Per BSE Announcement Dated on: 07/11/2024) | ||
Board Meeting | 5 Aug 2024 | 27 Jul 2024 |
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the first quarter ended June 30 2024; and Other corporate matters. Please find enclosed herewith the Outcome of Board meeting held on Aug 05, 2024 (As per BSE Announcement Dated on 05/08/2024) | ||
Board Meeting | 8 May 2024 | 29 Apr 2024 |
Final Dividend & Audited Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve 1. The standalone and consolidated audited financial results of the Company for the quarter and year ended March 31, 2024; 2. Recommend the dividend, if any, for the financial year ended March 31, 2024; and 3. Other corporate matters Outcome of Board meeting held on May 08, 2024. as per attachment Recommendation of Final Dividend of ?1/- per equity share i.e., 100% of the face value, for the financial year ended March 31, 2024 Re-appointment of Whole-time Directors. Re-appointment of Cost Auditor for FY2024-25 Grant of 2,41,470 ESOPs under the Employee Stock Option Plan 2018 (As Per BSE Announcement Dated on 08/05/2024) |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.